Eleven life science innovation projects receive grants from Knut and Alice Wallenberg Foundation and SciLifeLab's Proof-of-Concept program

The grants aim to strengthen the path from academic research to innovation and commercial application in life science.

Go to the press release

Foto: Andreas Palmén

A new national arena for forest research and data analysis in Sweden

The arena is funded by Knut and Alice Wallenberg Foundation, the Kempe Foundations, the Swedish University of Agricultural Sciences, as well as companies and organisations within the forest sector, and represents a total investment of approximately SEK 180 million.

Go to the press release from the Swedish University of Agricultural Sciences 

"We will discover things we didn't even know we were looking for"

 

For over hundred years Knut and Alice Wallenberg Foundation has given long term support for basic research in Sweden. For recent years, every year, more than two billion Swedish crowns – for building new knowledge for a brighter future.

flaskor-scotti-nv.jpg
The flow of complex fluids is impacted by velocity, pressure, and the softness of its particles. The last-mentioned factor is the one that has been least explored. Andrea Scotti wants to understand the effect of softness on the particle flow in both synthetic and natural complex fluids. This knowledge might pave the way for creating a synthetic form of blood.
drew-pekar.jpg
Photo Magnus Bergström
Wallenberg Scholar David Drew is developing new ways to study how the body's cells regulate pH level, salt content and volume using transport proteins in the cell's membrane.
reiman-ritar.jpg
Photo Kennet Ruona
Wallenberg Scholar Stephanie Reimann is exploring how modern quantum optics technology can place atoms in states where they possess new physical properties.
En man i labbrock arbetar med pipetter i ett laboratorium.
Photo Magnus Bergström
What role does the signaling substance NO‑ferroheme play in the process whereby our vessels dilate and blood pressure falls? This is one of the questions that Jon Lundberg and his research colleagues at Karolinska Institutet are addressing. Their goal is to contribute to improved treatments for cardiovascular disease.